DNA/protein flow cytometry as a predictive marker of malignancy in dysplasia-free Barren's esophagus. Thirteen-year follow-up study on a cohort of patients

Communications in Clinical Cytometry

Volumn 34, Issue 6, 1998, Pages 257-263

  Teodori, Laura ^a   Göhde, Wolfgang ^b   Persiani, Massimo ^a   Ferrario, Fabio ^c   Danesi, Donatella Tirindelli ^d   Scarpignato, Carmelo ^d   Tondo, Ugo Di ^e   Alò, Piero ^b   Capurso, Lucio ^c  

^a ENEA C R CASACCIA   (Italy)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c SAN FILIPPO NERI HOSPITAL   (Italy)

^d UNIVERSITY OF PARMA   (Italy)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Barren's esophagus; Dna protein cellular content; Dual parameter flow cytometry; Early cancer detection; Predictive markers

Indexed keywords

ADULT; AGED; ANEUPLOIDY; ARTICLE; BARRETT ESOPHAGUS; CANCER RISK; CELL CYCLE G1 PHASE; CLINICAL ARTICLE; COHORT ANALYSIS; DNA CONTENT; DYSPLASIA; EARLY DIAGNOSIS; FEMALE; FLOW CYTOMETRY; FOLLOW UP; GASTROESOPHAGEAL REFLUX; HUMAN; INTESTINE METAPLASIA; MALE; PREDICTION; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN DNA INTERACTION;

ADULT; AGED; ANEUPLOIDY; BARRETT ESOPHAGUS; CELL TRANSFORMATION, NEOPLASTIC; COHORT STUDIES; DNA; EVALUATION STUDIES; FEMALE; FLOW CYTOMETRY; FOLLOW-UP STUDIES; HUMANS; MALE; METAPLASIA; MIDDLE AGED; PRECANCEROUS CONDITIONS; PROGNOSIS; PROTEINS; RISK; TUMOR MARKERS, BIOLOGICAL;

EID: 0010005673     PISSN: 01964763     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0320(19981215)34:6<257::AID-CYTO3>3.0.CO;2-S     Document Type: Article

References (39)

1. Spechler SJ, Goyal RK. Medical progress: Barren's esophagus. N EnglJ Med 1986:315:362-371.
2. Phillips RW, Wong RKII Barren's esophagus: natural history, incidence, etiology- and complications. Gastroenterol Clin North Am 1991:20:791-816.
3. Sjogren RW, Johnson LF. Barrett's esophagus: a review. Am J Med 1983:74:313-320.
4. Hamilton SR. Pathogenesis of columnar cell-lined (Barrett's) esophagus. In: Spechler SJ, Goyal RK, editors. Barrett's esophagus: pathophysiology, diagnosis and management. New York: Elsevicr; 1985. p 29-37.
5. Cameron AJ, Ott BJ, Payne WS. Incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus. N EnglJ Med 1985:313:857.
6. Spechler SJ, Robbins All, Rubins HB, Vincent ME, Heeren T, Doos WG, Cotton T, Schimmel EM. Adenocarcinoma and Barren's esophagus: an overrated risk? Gastroenterology 1984:87:927-933.
7. Skinner DB, Walter BC, Riddell RII, Schmidt H, lascone C, De Meester TR. Barren's esophagus: comparison of benign and malignant cases. AnnSurg 1983:198:554-566.
8. Peters JII, Clark GW, Ireland AP, Chandrasoma P, Smyrk TC, De Meester TR. Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically sun-eyed and nonsurveyed patients. J Thorac Cardiovasc Surg 1994;808:813-821.
9. Hameeteman W, Tytgat GN, Houthoff HJ, van den Tweel JG. Barrett's esophagus: development of dysplasia and adenocarcinoma. Gastroenterology 1989:96:1249-1256.
10. Rotterdam H, Sheanan DG. Biopsy diagnosis of the digestive tract. 2nd edition. New York: Raven Press; 1993.
11. Haggitt RC. Barren's esophagus, dysplasia, and adenocarcinoma. Hum Pathol 1994;25:982-993-
12. Clark GW, Ireland AP, De Meester TR. Dysplasia in Barren's esophagus: diagnosis, surveillance and treatment. Dig Dis 1996;l4:213-227.
13. Reid BJ, Haggitt RC, Rubin CE, Roth G, Surawicz CM, Van Belle G, Lewin K, Weinstein WM, Antonioli DA, Goldman H. Observer variation in the diagnosis of dysplasia in Barrett's esophagus. Hum Pathol 1988:19:166-178.
14. Mauro F, Teodori L, Schumann J, Göhde W. Flow cytometry as a tool for the prognostic assessment of human neoplasia. Int J Radiât Oncol BiolPhys 1986:12:625-636.
15. Teodori L, Capurso L, Cordelli E, De Vita R, Koch M, Tarquini M, Pallone F, Mauro F. Cytometrically determined relative DNA content as an indicator of neoplasia in gastric lesion. Cytometry 1984:5:63-70.
16. Fennerty MB, Sampliner RE, Way D, Riddell R, Steinbronn K, Garewal US. Discordance between flow cytometric abnormalities and dysplasia in Barrett's esophagus. Gastroenterology 1989:97:815-820.
17. Klein G, Klein E. Evolution of tumors and the impact of molecular oncology. Nature 1985:315:190-195.
18. Sager R. Genomic rearrangements and the origin of cancer. In: German J, editor. Chromosome mutation and neoplasia. New York: Alan R. Liss; 1983. p 333-346.
19. Rabinovitch PS, Rcid BJ, Haggitt RC, Norwood TU, Rubin CE. Progression to cancer in Barren's esophagus is associated with genomic instability. Lab Invest 1989;60:65-71.
20. Teodori L, Tirindelli-Danesi D, Cordelli E, UcceUi R, De Vita R, Spano M, Mauro F, Schillaci A, Moraldi A, Capurso L, Stipas, S. Potential prognostic significance of flow cytometrically determined DNA abnormally in GI tract human tumors. In: Andreeff M, editor. Clinical cytometry. Annals of the New York Academy of Sciences. Vol 468. 1986. p 291-301.
21. Menke-Pluymers MB, Mulder All, Hop WC, van Blankenstein M, Tilanus IIW. Dysplasia and aneuploidy as markers of malignant degeneration in Barren's oesophagus. The Rotterdam Oesophageal Tumor Study Group. Gut 1994:35:1348-1351.
22. Teodori L, Trinca ML, Salvati F, Berettoni L, Stomiello G, Göhde W. Cellular heterogeneity of DNA/total-protein content in human lung tumors, as determined by flow cytometry. Int J Cancer 1992;50:845853.
23. Auer GU, Ono J, Casperson T. Cytochemical identification of quiescent and growth-activated tumor cells. Anal Quant Cytol 1983;5:5-8.
24. Levine DS, Haggitt RC, Blount PL. An endoscopie biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barren's esophagus. Gastroenterology 1993:105:40-50.
25. Paull A, Trier JS, Dalton D, Camp RC, Loeb P, Goyal RK. The histologie spectrum of Barren's esophagus. N EnglJ Med 1976;295:476.
26. Spechler SJ. Barren's esophagus: what's new and what to do. Am J Gastroenterol 1989:84:220-223.
27. Katzka DA. Barren's esophagus: detection and management. Gastroenterol Clin North Am 1989:18:339-357.
28. Hamilton SR, Smith RRL. The relationship between columnar epithelial dysplasia and invasive adenocarcinoma arising in Barren's esophagus. Am J Clin Pathol 1987;87:301-312.
29. Rustgi AK. Biomarkers for malignancy in the columnar-lined esophagus. Gastroenterol Clin North Am 1997;26:599-606.
30. Reynolds RP. Pathophysiology and investigation of Barren's esophagus. Can J Gastroenterol 1997; 11 (SupplB):41B-44B.
31. Salvati F, Teodori L, Trinca ML, Pasquali-Lasagni R, Göhde W. The relevance of flow-cytometric DNA content in the evaluation of lung cancer. J Cancer Res Clin Oncol 1994;120:233-239.
32. Cicconetti F, Teodori L, Persian! M, Di Tondo U, Alo P, Marci A, Brun S, Göhde W. Increased number of cancer cells in bronchial washing fluid detected by combining conventional cytology and highresolution Dow cytometry. J Cancer Res Clin Oncol 1997:123:571577.
33. Gledhill BL, Evenson DP, Pinkel D. Flow cytometry and sorting of sperm and male germ cells. In: Melamed MR, Lindmo T, Mendelsohn ML, editors. Flow cytometry and sorting. 2nd edition. New York: John Wiley & Sons; 1990. p 531-551.
34. Otto FJ, Hacker U, ZanteJ, Schumann J, Göhde W, Meistrich ML Flow cytometry of human spermatozoa. Histochemistry 1979;6l:249-254.
35. Teodori L, Capurso L, Cordelli E, De Vita R, Koch M, Tarquini M, Pallone F, Mauro F. Cytometrically determined relative DNA content as an indicator of neoplasia in gastric lesions. Cytometry 1984;5: 63-70.
36. Reid BJ, Blount PL, Rubin CE, Levine DS, Haggitt RC, Rabinovitch PS. Flow-cytometric and histological progression to malignancy in Barren's esophagus: prospective endoscopie surveillance of a cohort. Gastroenterology 1992;102:1212-1219.
37. Pollack A, Moulis H, Block NL, Irvin GL HI. Quantitation of cell kinetic responses using simultaneous flow cytometric measurements of DNA and nuclear protein. Cytometry 1984:5:473-481.
38. Ffrench, M, Bryon PA, Fiere D, Vuvan II, Gentilhomme O, Adeleine P, Viala JJ. Cell cycle, protein content and nuclear size in acute myeloid leukemia. Cytometry 1985:6:47-53.
39. Levine DS, Reid BJ, Haggitt RC, Rubin CE, Rabinovitch PS. Correlation of ultrastructural aberration with dysplasia and flow cytometric abnormalities in Barren's epithelium. Gastroenterology 1989:96:355367.